MoneyWorks4Me

Vista Pharmaceuticals informs about unaudited financial results

01 Nov 2016 Evaluate

Vista Pharmaceuticals has informed that a meeting of the Board of Directors of the Company will be held on November 11, 2016, to consider and approve the Unaudited Financial Results of the Company for the quarter/half year ended September 30, 2016.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1818.55
Dr. Reddys Labs. 1216.10
Cipla 1346.05
Lupin 2034.40
Zydus Lifesciences 1150.90
View more..